| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA2089163
Max Phase: Preclinical
Molecular Formula: C24H32N4O4
Molecular Weight: 440.54
Molecule Type: Protein
Associated Items:
Representations
Canonical SMILES: CC(C)C[C@H](NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O
Standard InChI: InChI=1S/C24H32N4O4/c1-15(2)12-21(28-23(31)19(25)13-16-6-4-3-5-7-16)24(32)27-20(22(26)30)14-17-8-10-18(29)11-9-17/h3-11,15,19-21,29H,12-14,25H2,1-2H3,(H2,26,30)(H,27,32)(H,28,31)/t19-,20-,21-/m0/s1
Standard InChI Key: SPAOJPLBVAYAEK-ACRUOGEOSA-N
Associated Targets(non-human)
Snake venom metalloproteinase Bap1 31 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 440.54 | Molecular Weight (Monoisotopic): 440.2424 | AlogP: 1.01 | #Rotatable Bonds: 11 |
| Polar Surface Area: 147.54 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 5 |
| #RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 1 |
| CX Acidic pKa: 9.50 | CX Basic pKa: 7.70 | CX LogP: 1.67 | CX LogD: 1.32 |
| Aromatic Rings: 2 | Heavy Atoms: 32 | QED Weighted: 0.35 | Np Likeness Score: 0.18 |
References
| 1. Villalta-Romero F, Gortat A, Herrera AE, Arguedas R, Quesada J, de Melo RL, Calvete JJ, Montero M, Murillo R, Rucavado A, Gutiérrez JM, Pérez-Payá E.. (2012) Identification of new snake venom metalloproteinase inhibitors using compound screening and rational Peptide design., 3 (7): [PMID:24900507] [10.1021/ml300068r] |
Source
Source(1):